AbbVie Price To Sales Ratio from 2010 to 2024
| ABBV Stock | USD 171.09 3.34 1.91% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 5.04412828 | Current Value 3.39 | Quarterly Volatility 0.72961639 |
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
AbbVie | Price To Sales Ratio |
Latest AbbVie's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of AbbVie Inc over the last few years. Price to Sales Ratio is figured by comparing AbbVie Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on AbbVie sales, a figure that is much harder to manipulate than other AbbVie Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. AbbVie's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 5.44 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
AbbVie Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 4.22 | |
| Geometric Mean | 4.16 | |
| Coefficient Of Variation | 17.29 | |
| Mean Deviation | 0.56 | |
| Median | 4.21 | |
| Standard Deviation | 0.73 | |
| Sample Variance | 0.53 | |
| Range | 2.5394 | |
| R-Value | 0.26 | |
| Mean Square Error | 0.54 | |
| R-Squared | 0.07 | |
| Significance | 0.36 | |
| Slope | 0.04 | |
| Total Sum of Squares | 7.45 |
AbbVie Price To Sales Ratio History
About AbbVie Financial Statements
AbbVie investors use historical fundamental indicators, such as AbbVie's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 5.04 | 3.39 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.